Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 60  Show
  1. 1
    "The human Pim-2 proto-oncogene and its testicular expression."
    Baytel D., Shalom S., Madgar I., Weissenberg R., Don J.
    Biochim. Biophys. Acta 1442:274-285(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  2. 2
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12930 other entries.

  3. 3
    "Genomic organization of the human UDP-galactose transporter gene."
    Ishida N., Miura N., Yamauchi M., Kawakita M.
    Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The DNA sequence of the human X chromosome."
    Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.
    , Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., Rogers J., Bentley D.R.
    Nature 434:325-337(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2057 other entries.

  5. 5
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Uterus.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50481 other entries.

  6. 6
    "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection."
    Leong W.F., Chow V.T.
    Cell. Microbiol. 8:565-580(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: INDUCTION, IDENTIFICATION BY MASS SPECTROMETRY.
    Category: Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 19 other entries.

  7. 7
    "Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels."
    Morishita D., Katayama R., Sekimizu K., Tsuruo T., Fujita N.
    Cancer Res. 68:5076-5085(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF CDKN1B.
    Category: Function, PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 and mapped to 13 other entries.

  8. 8
    "Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell."
    Gong J., Wang J., Ren K., Liu C., Li B., Shi Y.
    J. Surg. Res. 153:17-22(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, TISSUE SPECIFICITY.
    Category: Function, Expression.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells."
    Wang Z., Zhang Y., Gu J.J., Davitt C., Reeves R., Magnuson N.S.
    Int. J. Biochem. Cell Biol. 42:1030-1038(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION IN PHOSPHORYLATION OF CDKN1A.
    Category: Function, PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  10. 10
    "Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor."
    Bullock A.N., Russo S., Amos A., Pagano N., Bregman H., Debreczeni J.E., Lee W.H., von Delft F., Meggers E., Knapp S.
    PLoS ONE 4:E7112-E7112(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH RUTHENIUM-PYRIDOCARBAZOLE-1.
    Category: Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).
  11. 11
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 452 other entries.

  12. 12
    "The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death."
    Yan B., Zemskova M., Holder S., Chin V., Kraft A., Koskinen P.J., Lilly M.
    J. Biol. Chem. 278:45358-45367(2003) [PubMed] [Europe PMC] [Abstract]
    Annotation: pim-2 functions similarly to pim-1 as a pro-survival kinase; BAD is a legitimate PIM-2 substrateImported.
    Source: GeneRIF:11040.

    This publication is cited by 1 and mapped to 15 other entries.

  13. 13
    "Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma."
    Cohen A.M., Grinblat B., Bessler H., Kristt D., Kremer A., Schwartz A., Halperin M., Shalom S., Merkel D., Don J.
    Leuk. Lymphoma 45:951-955(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: hPim-2 mRNA expression in NHL was 1.5 to 2.6 times higher in involved splenic foci compared to nearby uninvolved regions. hPim-2 mRNA was increased 3-folds in B-CLL over normal B-cellsImported.
    Source: GeneRIF:11040.

    This publication is mapped to 1 other entry.

  14. 14
    "Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation."
    Hammerman P.S., Fox C.J., Cinalli R.M., Xu A., Wagner J.D., Lindsten T., Thompson C.B.
    Cancer Res. 64:8341-8348(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: transcriptional induction of Pim-2 initiates a novel NF-kappaB activation pathway that regulates cell survivalImported.
    Source: GeneRIF:11040.

    This publication is mapped to 3 other entries.

  15. 15
    "Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity."
    Rainio E.M., Ahlfors H., Carter K.L., Ruuska M., Matikainen S., Kieff E., Koskinen P.J.
    Virology 333:201-206(2005) [PubMed] [Europe PMC] [Abstract]
    Annotation: EBV-induced upregulation of Pim kinases and Pim-stimulated EBNA2 transcriptional activity may contribute to the ability of EBV to immortalize B-cells and predispose them to malignant growth.Imported.
    Source: GeneRIF:11040.

    This publication is mapped to 5 other entries.

  16. 16
    "Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer."
    Dai H., Li R., Wheeler T., Diaz de Vivar A., Frolov A., Tahir S., Agoulnik I., Thompson T., Rowley D., Ayala G.
    Prostate 65:276-286(2005) [PubMed] [Europe PMC] [Abstract]
    Annotation: Up-regulation of Pim-2 is associated with disease progression and perineural invasion in prostate cancer.Imported.
    Source: GeneRIF:11040.

    This publication is mapped to 1 other entry.

  17. 17
    Category: Interaction.
    Source: IntAct:Q9P1W9.

    This publication is mapped to 1656 other entries.

  18. 18
    Category: Interaction.
    Source: IntAct:Q9P1W9.

    This publication is mapped to 1504 other entries.

  19. 19
    "Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL."
    Macdonald A., Campbell D.G., Toth R., McLauchlan H., Hastie C.J., Arthur J.S.
    BMC Cell Biol. 7:1-1(2006) [PubMed] [Europe PMC] [Abstract]
    Annotation: All three Pim kinase family members predominantly phosphorylate Bad on Ser112 and in addition are capable of phosphorylating Bad on multiple sites associated with the inhibition of the pro-apoptotic function of Bad in HEK-293 cellsImported.
    Source: GeneRIF:11040.

    This publication is mapped to 13 other entries.

  20. 20
    "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration."
    Lim J., Hao T., Shaw C., Patel A.J., Szabo G., Rual J.-F., Fisk C.J., Li N., Smolyar A., Hill D.E., Barabasi A.-L., Vidal M., Zoghbi H.Y.
    Cell 125:801-814(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q9P1W9.

    This publication is mapped to 566 other entries.

  21. 21
    "The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes."
    Wernig G., Gonneville J.R., Crowley B.J., Rodrigues M.S., Reddy M.M., Hudon H.E., Walz C., Reiter A., Podar K., Royer Y., Constantinescu S.N., Tomasson M.H., Griffin J.D., Gilliland D.G., Sattler M.
    Blood 111:3751-3759(2008) [PubMed] [Europe PMC] [Abstract]
    Annotation: expression of the Myc and Pim proto-oncogenes by Jak2V617F was found to be FERM domain dependent.Imported.
    Source: GeneRIF:11040.

    This publication is mapped to 80 other entries.

  22. 22
    "Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin."
    Basu S., Golovina T., Mikheeva T., June C.H., Riley J.L.
    J. Immunol. 180:5794-5798(2008) [PubMed] [Europe PMC] [Abstract]
    Annotation: Foxp3 can regulate pim 2 expression.Imported.
    Source: GeneRIF:11040.

    This publication is mapped to 6 other entries.

  23. 23
    "14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2--Potential interplay with the PKB/Akt pathway and p14(ARF)."
    Wood N.T., Meek D.W., Mackintosh C.
    FEBS Lett. 583:615-620(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q9P1W9.

    This publication is mapped to 9 other entries.

  24. 24
    "Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway."
    Ren K., Zhang W., Shi Y., Gong J.
    Pathol. Oncol. Res. 16:229-237(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: we infer that Pim-2 could activate API-5 to inhibit the apoptosis of liver cells and NF-kappaB is the key regulatorImported.
    Source: GeneRIF:11040.

    This publication is mapped to 5 other entries.

  25. 25
    "Expanding the substantial interactome of NEMO using protein microarrays."
    Fenner B.J., Scannell M., Prehn J.H.
    PLoS ONE 5:e8799-e8799(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q9P1W9.

    This publication is mapped to 77 other entries.

1 to 25 of 60  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health